In Q3 2023, U.S. digital health startups raised $2.5 billion across 119 deals, marking the second-lowest quarter by funding since Q4 2019, as reported by Rock Health. Despite the tighter funding cycle, investors are showing interest in startups that focus on new treatment pathways and nonclinical workflow solutions. The total funding for 2023 so far stands at $8.6 billion across 365 deals. The digital health sector saw a decline in funding after the surge in 2021, which was driven by the shift to telehealth during the COVID-19 pandemic. The current trend suggests a more conservative approach by investors. The funding focus has shifted from pandemic-related areas to digital health products and services that support disease treatment, nonclinical workflow, and management of complex conditions. Mental health remains the top-funded area, with startups in nephrology also seeing significant funding. There’s also a growing interest in value-based care enablement.